Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat, Youssef M.K. Farag et autres
98 citationsAnnals of Internal Medicine
Leidulv Solnør
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
4Publications signalées
347Citations signalées
0Affiliations récentes
Domaines associés
Hormonal Regulation and HypertensionBlood Pressure and Hypertension StudiesHeart Failure Treatment and ManagementDiabetes Treatment and ManagementIon Transport and Channel Regulation
Publications récentes
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897
Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et autres
0 citationsDiabetes Care
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt et autres
212 citationsDiabetes Care
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos et autres
37 citationsDiabetes Care
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.